The global uveitis treatment market reached approximately $1.47 billion in 2022 across seven major markets and is projected to grow significantly through 2034, driven by emerging therapies and expanded treatment indications.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.